申请人:LG Chemical, Ltd.
公开号:US06500846B1
公开(公告)日:2002-12-31
The present invention relates to a novel flavone derivative, pharmaceutically acceptable salt, hydrate, solvate and isomer thereof which is useful as an inhibitor against Cyclin Dependent Kinase (CDK), a process for preparation thereof, and a composition of anti-cancer agent or agent for treating neurodegenerative disease comprising this compound as an active ingredient.
本发明涉及一种新型黄酮衍生物,其药学上可接受的盐、水合物、溶剂化物和异构体,可用作抑制细胞周期素依赖性激酶(CDK)的抑制剂,其制备方法,以及包含该化合物作为活性成分的抗癌剂或治疗神经退行性疾病的药物组合物。